Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual cyclin-dependent kinase 4/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells

Published:2017-06-18 Issue:15 Volume:174 Page:2427-2443
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Chen Liang¹^ORCID,Pan Jingxuan¹^ORCID

Affiliation:

1. Jinan University Institute of Tumor Pharmacology, College of Pharmacy; Jinan University; Guangzhou China

Funder

the National Natural Science Fund

the Research Foundation of Guangzhou Bureau of Science and Technology, and Natural Science Foundation of Guangdong province

the Research Foundation of Education Bureau of Guangdong Province, China

Natural Science Foundation of Guangdong Province

Research Foundation of Guangzhou Bureau of Science and Technology

Research Foundation of Education Bureau of Guangdong Province, China

National Natural Science Funds

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13836/fullpdf

Reference58 articles.

1. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015a

2. The Concise Guide to PHARMACOLOGY 2015/16: Overview;Alexander;Br J Pharmacol,2015b

3. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells;Anders;Cancer Cell,2011

4. A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4/6;Baughn;Cancer Res,2006

5. DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway;Chen;Mol Cancer,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18

2. Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells;European Journal of Medical Research;2024-05-22

3. Network pharmacology and molecular docking reveal the mechanisms of curcumin activity against esophageal squamous cell carcinoma;Frontiers in Pharmacology;2024-04-03

4. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo;Molecular Biology Reports;2024-03-27

5. Clinical considerations of CDK4/6 inhibitors in HER2 positive breast cancer;Frontiers in Oncology;2024-01-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3